Contineum Therapeutics appoints Troy Ignelzi to board as Audit Committee Chair

Contineum Therapeutics, Inc.

Troy Ignelzi appointed as Class I director and Chair of Audit Committee, effective May 20, 2024.
Evert Schimmelpennink stepped down from Audit Committee; Class I directors now Ignelzi and Olivia Ware.
Ignelzi is CFO of Rapport Therapeutics; previously CFO at Karuna Therapeutics, scPharma, Juventas.
Ignelzi will receive standard non-employee director compensation including an option for 23,150 shares.
Board determined Ignelzi independent and an audit committee financial expert under SEC/Nasdaq rules.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Troy Ignelzi

Class I Director and Chair of Audit Committee

CTNM · Contineum Therapeutics, Inc.

Effective: 2024-05-20
Filed: May 20, 2024, 7:59 PM ET

On May 20, 2024, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Troy Ignelzi as a member of its Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Troy Ignelzi was appointed as Class I Director and Chair of Audit Committee at Contineum Therapeutics, Inc..

Action: appointed
Role: Class I Director and Chair of Audit Committee

Exact text from the filing

On May 20, 2024, the board of directors (the “Board”) of Contineum Therapeutics, Inc. (the “Company”) appointed Troy Ignelzi as a member of its Board, effective immediately.

View on SEC.gov

Contineum Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-017651

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.